Nitric Oxide Synthase Inhibition Enhances Tumor Control with Radiation
Author Information
Author(s): Cardnell Robert J. G., Mikkelsen Ross B.
Primary Institution: Virginia Commonwealth University
Hypothesis
Does the nitric oxide synthase inhibitor, NG-nitro-L-arginine (L-NNA), enhance the effectiveness of ionizing radiation in controlling squamous carcinoma tumor growth?
Conclusion
The combination of L-NNA and radiation significantly delays tumor growth and enhances survival in mice with squamous carcinoma xenografts.
Supporting Evidence
- L-NNA treatment stopped tumor growth for at least 10 days.
- The combination of L-NNA and radiation caused 82% tumor cell killing.
- Animals receiving both L-NNA and radiation survived significantly longer than those receiving either treatment alone.
Takeaway
This study found that a special medicine can help radiation therapy work better against certain tumors, making them shrink and helping mice live longer.
Methodology
Mice with squamous carcinoma xenografts were treated with L-NNA and exposed to ionizing radiation, followed by analysis of tumor growth and survival.
Limitations
The study primarily focuses on mouse models, which may not fully replicate human responses.
Participant Demographics
Athymic NCr-nu/nu male mice, 5-6 weeks old.
Statistical Information
P-Value
0.00007
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website